Novel GO-COO-β-CD/CA inclusion: Its blood compatibility, antibacterial property and drug delivery

Drug Delivery

Volumn 21, Issue 5, 2014, Pages 362-369

  Xiao, Yinghong ^a   Fan, Yunting ^a   Wang, Weiyang ^a   Gu, Hao ^a   Zhou, Ninglin ^a,b   Shen, Jian ^a,b  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Anti bacteria; Blood compatibility; Drug carrier; Drug delivery; GO COO CD CA inclusion

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; CARBOXYLATED GRAPHENE BETA CYCLODEXTRIN CHLORHEXIDINE ACETATE; CHLORHEXIDINE ACETATE; GRAPHENE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA CYCLODEXTRIN; BIOMATERIAL; CHLORHEXIDINE; DRUG CARRIER; GRAPHITE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BLOOD COMPATIBILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ESCHERICHIA COLI; HEK293 CELL LINE; HEMOLYSIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REACTION TIME; SIMULATION; STAPHYLOCOCCUS AUREUS; X RAY DIFFRACTION; CELL LINE; DRUG EFFECTS; PROCEDURES; SOLUBILITY;

ANTI-BACTERIAL AGENTS; BETA-CYCLODEXTRINS; BIOCOMPATIBLE MATERIALS; CELL LINE; CHLORHEXIDINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ESCHERICHIA COLI; GRAPHITE; HEK293 CELLS; HUMANS; SOLUBILITY; STAPHYLOCOCCUS AUREUS; X-RAY DIFFRACTION;

EID: 84904981383     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.846997     Document Type: Article

References (24)

1. Acar A, Uygur F, Diktas H, et al. (2011). Comparison of silvercoated dressing (Acticoat (R)), chlorhexidine acetate 0.5% (Bactigrass (R)) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. Burns 37: 882-5.
2. Agarwal A, Nelson TB, Kierski PR, et al. (2012). Polymeric multilayers that localize the release of chlorhexidine from biologic wound dressings. Biomaterials 33:6783-92.
3. Baek JS, Cho CW. (2013). 2-Hydroxypropyl-beta-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells. J Pharm Pharmacol 65:72-8.
4. Chaturvedi K, Ganguly K, Kulkarni AR, et al. (2011). Cyclodextrinbased siRNA5AQ1/4delivery nanocarriers: a state-of-the-art review. Expert Opin Drug Del 28:1455-68.
5. Chowdhury SM, Lalwani G, Zhang KV, et al. (2013). Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials 34: 283-93.
6. Dembereldorj U, Kim M, Kim S, et al. (2012). A spatiotemporal anticancer drug release platform of Pegylated graphene oxide triggered by glutathione in vitro and in vivo. J Mater Chem 22: 23845-51.
7. Ferraz CCR, Gomes B, Zaia AA, et al. (2001). In vitro assessment of the antimicrobial action and the mechanical ability of chlorhexidine gel as an endodontic irrigant. J Endodont 27:452-5. (Pubitemid 33754012)
8. Geim AK. (2009). Graphene: status and prospects. Science 324:1530-34.
9. Katsnelson MI, Novoselov KS. (2007). Graphene: new bridge between condensed matter physics and quantum electrodynamics. Solid State Commun 143:3-13. (Pubitemid 46874504)
10. Kuila T, Bose S, Khanra P, et al. (2011). Recent advances in graphenebased biosensors. Biosens Bioelectron 26:4637-48.
11. Liu Z, Robinson JT, Sun X, et al. (2008). Pegylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 130: 10876-7.
12. Lu F, Zhang SH, Gao HJ, et al. (2012). Protein-decorated reduced oxide graphene composite and its application to SERS. Acs Appl Mater Inter 4:3278-84.
13. Meng N, Zhou NL, Zhang SQ, et al. (2009). Controlled release and antibacterial activity chlorohexidine acetate (CA) intercalated in montmorillonite. Int J Pharmaceut 382:45-9.
14. Moya-Ortega MD, Alvarez-Lorenzo C, Concheiro A, et al. (2012). Cyclodextrin-based nanogels for pharmaceutical and biomedical applications. Int J Pharmaceut 428:152-63.
15. Murayama N, Terada Y, Okuaki M, et al. (2011). Dose assessment of 2% chlorohexidine acetate for canine superficial pyoderma. Vet Dermatol 22:449-53.
16. Novoselov KS, Geim AK, Morozov SV, et al. (2005). Two-dimensional gas of massless Dirac fermions in graphene. Nature 438:197-200. (Pubitemid 41599867)
17. Pei H, Li J, Lv M, et al. (2012). A graphene-based sensor array for highprecision and adaptive target identification with ensemble aptamers. J Am Chem Soc 134:13843-9.
18. Shen AJ, Li DL, Cai XJ, et al. (2012). Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment. J Biomed Mater Res A 100A:2499-506.
19. Trotta F, Zanetti M, Cavalli R. (2012). Cyclodextrin-based nanosponges as drug carriers. Beilstein J Org Chem 8:2091-9.
20. Wu J, Wang YS, Yang XY, et al. (2012). Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells. Nanotechnology 23:355101 (1-9).
21. Yang GH, Cao JT, Li LL, et al. (2013). Carboxymethyl chitosanfunctionalized graphene for label-free electrochemical cytosensing. Carbon 51:124-33.
22. Yannakopoulou K. (2012). Cationic cyclodextrins: cell penetrating agents and other diverse applications. J Drug Deliv Sci Tech 22: 243-9.
23. Yhaya F, Binauld S, Kim Y, et al. (2012). Shell cross-linking of cyclodextrin-based micelles via supramolecular chemistry for the delivery of drugs. Macromol Rapid Comm 33:1868-74.
24. Zhang LM, Xia JG, Zhao QH, et al. (2010). Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6:537-44.